Answers are grounded in this paper and cite their sources.
The goal of the study was exploring the range of variants of the PRL, PRLR, and PRLHR genes in women of reproductive age with nontumor hyperprolactinemia. In women with hyperprolactinemia of nontumor origin (n = 15) targeted high throughput sequencing of PRL, PRLR, and PRLHR genes was performed. The targeted panel of genes included coding regions and adjacent splicing sites. Analysis of the PRL, PRLR, and PRLHR genes revealed a number of rare and common variants. In the PRL gene, the common variant rs1205955 was identified (MAF А = 0.279). For the PRLR gene, the rare variant rs185353023 was identified in the 3'UTR (MAF A/C = 0.003) and 12 common variants were detected. For the PRLHR gene, ten common variants were identified. The maximum number of variants was localized in the 3'UTR region and introns. For the first time in Russia, targeted high throughput sequencing of the PRL, PRLR, and PRLHR genes was performed, according to the results of which no obvious pathological variants were revealed in the studied genes in women with an increased content of nonneoplastic prolactin. The discovered polymorphism in these genes allows further study of its association with impaired function of the prolactin component of hormonal regulation.
No takes yet. Share an insight, caveat, or question.
Shakhtshneider et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: